GCG and type 2 diabetes mellitus: Dipeptidyl peptidase-4 (DPP-4) inhibitors are considered incretin enhancers, because they inhibit the enzymatic degradation of incretins, in particular, GLP-1 [7] and therefore are established therapies for type 2 diabetes.